Litcius/Paper detail

Sociodemographic Characteristics of Infants Receiving Nirsevimab

Salomé Boutin, Marion Bertrand, Jérémie F. Cohen, Mahmoud Zureik, Martin Chalumeau, Marie-Joëlle Jabagi

2025JAMA Network Open9 citationsDOIOpen Access PDF

Abstract

This cohort study investigates inequalities by sociodemographic group in the receipt of nirsevimab immunization by infants in France from 2023 to 2024.

Topics & Concepts

ReceiptCohortMedicineCohort studyEnvironmental healthInequalityPediatricsDemographyImmunizationSociologyBusinessImmunologyInternal medicineMathematicsMathematical analysisAccountingAntigenImmunodeficiency and Autoimmune DisordersVaccine Coverage and HesitancyTuberculosis Research and Epidemiology
Sociodemographic Characteristics of Infants Receiving Nirsevimab | Litcius